Highlights
NASDAQ: BCLI       Brainstorm Cell
Last Price Today's Change   Day's Range   Trading Volume
3.85   -0.035 (0.90%)  3.82 - 3.881  50,200

Overview

 
Avg Volume (4 weeks):74,384
4 Weeks Range:3.65 - 4.04
4 Weeks Price Volatility (%):
51.28%
52 Weeks Range:2.98 - 4.50
52 Weeks Price Volatility (%):
57.24%
Average Price Target:-

Headlines



No recent Headlines for this stock.


Business Background

Brainstorm Cell Therapeutics Inc is a biotechnology company. The company is a developing novel adult stem cell therapies for debilitating neurodegenerative disorders such as Amyotrophic Lateral Sclerosis (ALS, also known as Lou Gehrig's disease), Multiple Sclerosis (MS), and Parkinson's disease (PD). Brainstorm's NurOwn, its proprietary process for the propagation of Mesenchymal Stem Cells (MSC) and differentiation into neurotrophic factor-(NTF) secreting cells (MSC-NTF), and their transplantation at, or near, the site of damage, offers the hope of more effectively treating neurodegenerative diseases.

  Be the first to like this.
 


 

3995  4101  641  182 

ActiveGainersLosers
Top 10 Active Counters
 NameLastChange 
 CELG 108.24+0.11 
 EEM 44.42-0.02 
 SPY 317.32+0.19 
 AMD 41.15-1.44 
 VXX 15.53-0.67 
 DHR 148.52-2.78 
 CHK 0.789+0.006 
 FXI 42.60-0.18 
 GE 11.34-0.10 
 BAC 34.44-0.24 
Partners & Brokers